Ebihara Y - Search Results

1

A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy.

Kubota N, Miyazawa K, Shoji N, Sumi M, Nakajima A, Kimura Y, Oshiro H, Ebihara Y, Ohyashiki K. Kubota N, et al. Among authors: ebihara y. Haematologica. 2003 Sep;88(9):EIM11. Haematologica. 2003. PMID: 12969824 No abstract available.

2

A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy.

Kubota N, Miyazawa K, Shoji N, Sumi M, Nakajima A, Kimura Y, Oshiro H, Ebihara Y, Ohyashiki K. Kubota N, et al. Among authors: ebihara y. Haematologica. 2003 Nov;88(11):EIM13. Haematologica. 2003. PMID: 14607766 No abstract available.

3

Pulmonary alveolar proteinosis as a terminal complication in myelodysplastic syndromes: a report of four cases detected on autopsy.

Shoji N, Ito Y, Kimura Y, Nishimaki J, Kuriyama Y, Tauchi T, Yaguchi M, Payzulla D, Ebihara Y, Ohyashiki K. Shoji N, et al. Among authors: ebihara y. Leuk Res. 2002 Jun;26(6):591-5. doi: 10.1016/s0145-2126(01)00178-3. Leuk Res. 2002. PMID: 12007507 Review.

4

Idiopathic retroperitoneal fibrosis associated with immunohematological abnormalities.

Oshiro H, Ebihara Y, Serizawa H, Shimizu T, Teshima S, Kuroda M, Kudo M. Oshiro H, et al. Among authors: ebihara y. Am J Med. 2005 Jul;118(7):782-6. doi: 10.1016/j.amjmed.2005.02.004. Am J Med. 2005. PMID: 15989914 No abstract available.

5

Telomerase activity during carcinogenesis in the bronchus.

Kakihana M, Yahata N, Hirano T, Honda H, Ikeda N, Kawate N, Konaka C, Ebihara Y, Ohyashiki K, Kato H. Kakihana M, et al. Among authors: ebihara y. Oncol Rep. 2002 Jan-Feb;9(1):43-9. Oncol Rep. 2002. PMID: 11748453

6

Immunohistochemical and ultrastructural investigation on cutaneous neuroendocrine carcinoma: report of a case and review of the literature.

Ishii H, Joshita T, Matsuyama N, Uchida T, Ishikawa A, Ebihara Y. Ishii H, et al. Among authors: ebihara y. Med Mol Morphol. 2006 Sep;39(3):164-8. doi: 10.1007/s00795-006-0323-x. Med Mol Morphol. 2006. PMID: 16998628

7

The characteristics of early bronchogenic carcinoma evaluated by cytomorphological features.

Konaka C, Miura H, Ikeda N, Hirano T, Nitadori J, Kato H, Ebihara Y. Konaka C, et al. Among authors: ebihara y. Lung Cancer. 2002 Dec;38(3):267-71. doi: 10.1016/s0169-5002(02)00216-7. Lung Cancer. 2002. PMID: 12445748

8

Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma.

Hirano T, Gong Y, Yoshida K, Kato Y, Yashima K, Maeda M, Nakagawa A, Fujioka K, Ohira T, Ikeda N, Ebihara Y, Auer G, Kato H. Hirano T, et al. Among authors: ebihara y. Lung Cancer. 2003 Aug;41(2):155-62. doi: 10.1016/s0169-5002(03)00194-6. Lung Cancer. 2003. PMID: 12871778

9

Histopathological evaluation of fluorescence bronchoscopy using resected lungs in cases of lung cancer.

Ikeda N, Hiyoshi T, Kakihana M, Honda H, Kato Y, Okunaka T, Furukawa K, Tsuchida T, Kato H, Ebihara Y. Ikeda N, et al. Among authors: ebihara y. Lung Cancer. 2003 Sep;41(3):303-9. doi: 10.1016/s0169-5002(03)00231-9. Lung Cancer. 2003. PMID: 12928121 Clinical Trial.

10

Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium.

Kato Y, Hirano T, Yoshida K, Yashima K, Akimoto S, Tsuji K, Ohira T, Tsuboi M, Ikeda N, Ebihara Y, Kato H. Kato Y, et al. Among authors: ebihara y. Lung Cancer. 2005 Jun;48(3):323-30. doi: 10.1016/j.lungcan.2004.11.012. Epub 2005 Jan 20. Lung Cancer. 2005. PMID: 15893000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

490 results

Search Page

Filters